机构:[1]Department of Rehabilitation Medicine, West China Hospital, Sichuan University, Chengdu, China.四川大学华西医院[2]West China School of Pharmacy, Sichuan University, Chengdu, China.[3]Key Laboratory of Rehabilitation Medicine in Sichuan Province/Rehabilitation Medicine Research Institute, Chengdu, China.
National Natural Science
Foundation of China (Grant No. 82173280), the Department
of Science and Technology of Sichuan Province (grant number:
2021YJ0450), and the Post-Doctor Research Project, West China
Hospital, Sichuan University (Grant No. 2019HXBH017).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类|2 区医学
小类|2 区药学
最新[2023]版:
大类|2 区医学
小类|2 区药学
第一作者:
第一作者机构:[1]Department of Rehabilitation Medicine, West China Hospital, Sichuan University, Chengdu, China.[2]West China School of Pharmacy, Sichuan University, Chengdu, China.
共同第一作者:
通讯作者:
通讯机构:[1]Department of Rehabilitation Medicine, West China Hospital, Sichuan University, Chengdu, China.[3]Key Laboratory of Rehabilitation Medicine in Sichuan Province/Rehabilitation Medicine Research Institute, Chengdu, China.
推荐引用方式(GB/T 7714):
Liu Xuan,Zhang Yiqian,Wu Xuyi,et al.Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer[J].Frontiers in pharmacology.2022,13:909821.doi:10.3389/fphar.2022.909821.
APA:
Liu Xuan,Zhang Yiqian,Wu Xuyi,Xu Fuyan,Ma Hongbo...&Xia Yong.(2022).Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer.Frontiers in pharmacology,13,
MLA:
Liu Xuan,et al."Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer".Frontiers in pharmacology 13.(2022):909821